Material Type

• Blood (whole) (2)
• Dried whole blood (3)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Pathogen DNA (Derivative) (1)
• Plasma (single spun) (3)
• Saliva (2)
• Serum (4)
• Sputum (1)
• Stool (2)
• Swab medium (3)
• Urine (random) (1)

Microscopic Assessment

• Not applicable (6)

Storage Temperature

• -35°C to -18°C (2)
• -85°C to -60°C (6)
• Liquid nitrogen (1)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (3)
• Followup records (3)
• Freezer temperature logs (2)
• Genomic datasets (2)
• Microbiological results (3)
• Participant Ethnicity (1)
• Physiological/biochemical measurements (2)
• Pre-analytical data (2)
• Quality indicators (2)
• Survey data (5)
• Treatment records (1)

Timeframe

• 0 - 3 months (4)
• 3 - 6 months (1)
• > 6 months (1)

Participant Count

• 1 - 10 (1)
• 11 - 100 (2)
• 101 - 500 (6)

Sex

• Both sexes (6)

Age Range

• Young adult (18 - 40 years) (6)

Biobank Services

• Ability to recontact (2)
• Cell culture (2)
• Data analytics (2)
• Infectious strain isolation (1)
• Molecular Extractions (1)
• Nucleic acid extraction (1)

Collection Type

• (1)
• Case-control (1)
• Cross-sectional (3)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (6)
• No Disease area restriction (6)
• No Genetic analysis restriction (6)
• No Human genetic analysis restriction (5)
• No restrictions (2)
• No Project specific restriction (5)
• No Scope of use restriction (4)

Collection Status

• Completed (1)
• In progress (4)
• Not-started (2)

Access Condition

• Open to applicants (4)
• Open only through collaboration (2)

Country

• Belgium (1)
• India (1)
• Kenya (1)
• Peru (1)
• South Africa (1)
• United States (1)

County